Caution to Poor Adherence With Immunosuppressant Medication That Causes Coma-Onset Autoimmune Encephalitis: A Case Report and Literature Review

Transplant Proc. 2023 Oct;55(8):1968-1971. doi: 10.1016/j.transproceed.2023.07.005. Epub 2023 Jul 28.

Abstract

Autoimmune encephalitis after liver transplantation (LT) is a rare disorder. This is because patients are usually in an immunosuppressed state after LT. Here, we report a rare case of autoantibody-negative autoimmune-encephalitis-induced coma after living-donor (LD) LT. A 45-year-old woman who underwent LDLT for primary biliary cholangitis (PBC) was brought to our hospital with the chief complaint of cognitive deficiency and an episode of memory loss. Physical examination, laboratory tests, and cerebrospinal fluid analysis revealed no significant findings. However, diffusion-weighted magnetic resonance imaging showed hyperintensity in the bilateral hippocampus. No autoantibodies associated with autoimmune encephalitis were detected. The diagnosis of antibody-negative autoimmune encephalitis was made on the basis of low immunosuppressive drug levels in the blood (indicative of poor adherence) and the presence of PBC as the autoimmune disease. The patient regained consciousness after intravenous methylprednisolone pulse therapy and plasma exchange. This case highlights that when examining patients with impaired consciousness after LDLT, it is important to consider autoimmune encephalitis as a potential diagnosis.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Autoimmune Diseases of the Nervous System* / diagnosis
  • Autoimmune Diseases of the Nervous System* / immunology
  • Autoimmune Diseases of the Nervous System* / therapy
  • Coma* / diagnosis
  • Coma* / immunology
  • Coma* / therapy
  • Female
  • Humans
  • Immunosuppressive Agents* / administration & dosage
  • Liver Cirrhosis, Biliary / surgery
  • Liver Transplantation* / adverse effects
  • Medication Adherence*
  • Methylprednisolone / administration & dosage
  • Middle Aged
  • Plasma Exchange

Substances

  • Immunosuppressive Agents
  • Methylprednisolone